TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bajaj Healthcare Ltd ( (IN:BAJAJHCARE) ) has provided an announcement.
Bajaj Healthcare Limited reported a strong performance for the first quarter of FY26, with a 12.5% increase in revenue to ₹1,488.4 million and a significant 66% growth in profit after tax to ₹118.3 million. The company achieved this despite challenging pricing conditions, by improving its product mix and leveraging operating efficiencies. The API export segment experienced a remarkable 68.4% year-on-year growth, driven by demand in regulated markets, while the formulations segment grew by 41.1% due to enhanced market penetration and strategic partnerships. The company is strategically realigning its portfolio towards value-added exports and differentiated molecules to sustain growth and profitability.
More about Bajaj Healthcare Ltd
Bajaj Healthcare Limited is a leading manufacturer in the pharmaceutical industry, specializing in Active Pharmaceutical Ingredients (APIs), intermediates, and formulations. The company focuses on both domestic and export markets, with a strategic emphasis on regulated markets and commercial CDMO supplies.
Average Trading Volume: 19,442
Technical Sentiment Signal: Buy
Current Market Cap: 16.32B INR
Learn more about BAJAJHCARE stock on TipRanks’ Stock Analysis page.